Home
Subscription
April 2024 issue
April 1, 2024 issue
March 2024 issue
February 2024 issue
January 2024 issue
BACK ISSUES
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2011 Issues
December 2011 Issue
• "I Never Told Her"
• New Therapeutic Agents Marketed in the United States in 2011 (Table)
• Index for 2011
November 2011 Issue
• Feature - Merchants of Death - Chain Pharmacy CEOs Must Stop the Sale of Cigarettes!
• New Drug Review: Telaprevir (Incivek)
October 2011 Issue
• Feature - Deception and Hypocrisy from Mail-Order Pharmacies
• New Drug Review: Ticagrelor (Brilinta)
September 2011 Issue
• Feature - The Tylenol Follies
• New Drug Review: Rivaroxaban (Xarelto)
August 2011 Issue
• Feature - Drug Shortages - Pharmaceutical Companies Have Caused This Problem and it is Their Responsibility to Resolve It!
• New Drug Review: Lurasidone hydrochloride (Latuda)
July 2011 Issue
• Feature - Express Scripts and Medco - A Fallen Giant or a Bigger Monster?
• New Drug Review: Vilazodone hydrochloride (Viibryd)
June 2011 Issue
• Feature - Pharmacy's Vision for 2015 OR a Large Surplus of Pharmacists?
• New Drug Review: Linagliptin (Tradjenta)
May 2011 Issue
• Feature - Mail-Order Pharmacy Programs - Limitations, Inequities, and Deception
• New Drug Review: Ceftaroline fosamil (Teflaro)
April 2011 Issue
• Feature - The Large Chains are Making a Mockery of our Profession - And our Profession is a Co-conspirator Through our Silence!
• New Drug Review: Azilsartan medoxomil (Edarbi)
March 2011 Issue
• Feature - TobBoth Patients and Health Care Have a Great Need for a Personal Touch!
• New Drug Review: Collagenase clostridium histolyticum (Xiaflex)
February 2011 Issue
• Feature - Priorities for our Profession
• New Drug Review: Pegloticase (Krystexxa)
January 2011 Issue
• Feature - A New Year, an Old Theme - Pharmacy Must Have a More Effective National Organizational Structure!
• New Drug Review: Fingolimod hydrochloride (Gilenya)
| |
